Oxidative damage, decreased autophagy, and defective proteostasis are frequently observed in Alzheimer's disease (AD) and contribute to neuronal death and disease progression. Familial AD is primarily caused by mutations in the presenilin genes, which have been shown to trigger excessive calcium release from ER stores into the mitochondria, altering mitochondrial metabolism and increasing production of reactive oxygen species1,2. This disruption in calcium homeostasis leads to severe neurodegeneration and behavioral abnormalities1. However, the molecular mechanisms linking mitochondrial dysfunction to neurodegeneration are not fully understood. We find evidence that loss of the Caenorhabditis elegans presenilin homolog
sel-12 results in mTORC1-mediated neurodegeneration. Suppression of mTORC1, either through constitutive activation of its inhibitor AMPK or knockdown of its activator RagA, restores the structural integrity of mechanosensory neurons in
sel-12 mutants and improves their behavioral response to touch. mTORC1 inhibition also partially rescues both the hypersensitivity to oxidative stress and the premature accumulation of poly-glutamine aggregates in
sel-12 mutants. Heterologous expression of amyloid-?, an aggregation-prone protein whose plaque deposition is considered a hallmark of AD, exacerbates the motility defects observed in
sel-12 mutants; mTORC1 inhibition significantly improves motility in this background. Additionally, we show that
sel-12 mutants exhibit decreased autophagy that is restored with mTORC1 inhibition. Altogether, these data point to an important role of the mTORC1 pathway in exacerbating the oxidative stress, proteostasis defects, and neuronal death in presenilin-driven AD. 1. Sarasija et al., 2018 eLife 7:
e33052. 2. Oksanen et al., 2017. Stem Cell Reports 9: 1885-1897.